Equity, tokenomics or hybrid
We connect you with the right investors according to your vision, not ours.
Our role is not to force your business into a standard fundraising playbook:
it’s to structure the format, process, and investor approach that best fit your specific context.
Multi-format fundraising
We structure equity rounds that respect your vision.
This means building your investor shortlist with strategic intent.
For Web3 projects, we design token architectures that align incentives.
For hybrid models, we create integrated structures.
Strategic due diligence
We conduct comprehensive audits of your strategic positioning.
We design optimal capital structures and benchmark against market comparables.
Investor readiness
We organize your data room with institutional-grade rigor.
We support investor-facing preparation throughout the fundraising process.
What you receive
Six situations we are built for, and the artefact each one produces.
Frequently asked, by sector
Tech & DeepTech
How is fundraising different for DeepTech versus software startups?
DeepTech cycles are longer and capital-intensive well before commercial revenue exists. We structure financing around technology readiness milestones rather than standard SaaS metrics, and sequence rounds to match validation stages instead of a fixed calendar.
Can DeepTech founders combine equity with token structures?
Yes, when there’s a genuine operational reason: for example tokenizing access to a dataset or a compute resource tied to the technology itself. Tokens without an operating rationale are not something we structure.
FinTech & Web3
How do you structure a raise that combines equity and token components?
Each instrument is assigned a distinct role in the structure, diligenced to the same standard, so neither undermines the other’s economics. Getting that split wrong is the most common way a hybrid round loses value.
Does a hybrid structure work for regulated FinTech models?
It can, but the regulatory perimeter has to be mapped first: payments, e-money, and securities frameworks vary by jurisdiction and directly affect what a token can and cannot represent legally.
MedTech & BioTech
How do you prepare a data room for MedTech or BioTech diligence?
Investors in this sector diligence the regulatory pathway and clinical or technical validation as closely as the financials. We go beyond the standard financial documents: the data room is built to answer the regulatory and technical questions investors will actually ask, not the questions a generic template anticipates.
Is tokenization ever relevant for MedTech fundraising?
Only in narrow cases, for example incentivizing data-sharing networks across research or clinical sites. It’s not a general fit for regulated MedTech financing, and we say so directly when it isn’t.